| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Onconova Therapeutics, Inc. | Director | Stock Option (right to purchase) | 66.5K | Aug 10, 2023 | Direct | ||
| Celldex Therapeutics, Inc. | Director | Non-Qualified Stock Option (right to buy) | 16.5K | Jun 13, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CLDX | Celldex Therapeutics, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 17, 2024 | Director |
| ONTX | Onconova Therapeutics, Inc. | Aug 10, 2023 | 1 | $0 | 4 | Aug 14, 2023 | Director |
| CLDX | Celldex Therapeutics, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director |
| ONTX | Onconova Therapeutics, Inc. | Aug 18, 2022 | 1 | $0 | 4 | Aug 19, 2022 | Director |
| CLDX | Celldex Therapeutics, Inc. | Jun 16, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
| ONTX | Onconova Therapeutics, Inc. | Sep 28, 2021 | 1 | $25K | 4 | Sep 28, 2021 | Director |
| ONTX | Onconova Therapeutics, Inc. | Jul 30, 2021 | 1 | $0 | 4 | Jul 30, 2021 | Director |
| CLDX | Celldex Therapeutics, Inc. | Jun 17, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |